ARMODACARE 150

What is ARMODACARE 150?

ARMODACARE 150 is a medicinal product in the form of oral tablets containing the active component armodafinil at a dose of 150 mg. The agent belongs to the pharmacological group of psychostimulants and nootropic drugs that help maintain wakefulness and enhance cognitive performance. The manufacturer of the drug is the pharmaceutical company Careclub, which specializes in the production of high-quality generics and innovative products to support the nervous system. In Careclub's product line, this remedy is presented alongside well-known categories such as ASSURANS, CENFORCE, and FILDENA, which demonstrates high standards of quality control at all stages of production. ARMODACARE 150 features a balanced dosage that allows achieving a pronounced therapeutic effect with a minimal risk of developing adverse reactions.

Armodafinil, which is the basis of ARMODACARE 150, is the R-enantiomer of modafinil — a substance with a proven ability to activate certain areas of the brain responsible for the sleep-wake cycle. Unlike classic amphetamine-type stimulants, armodafinil acts more selectively, without causing pronounced euphoria, tremors, or sharp fluctuations in blood pressure. The drug helps maintain clarity of thought, concentration of attention, and speed of reaction even in conditions of chronic sleep deprivation or intense mental workload. Due to the characteristics of its pharmacokinetics, ARMODACARE 150 has a long duration of action, which allows taking it once a day without the need for divided dosing. This makes the drug convenient for people with a busy work schedule, students during exams, and professionals whose activities require increased vigilance.

ARMODACARE 150 is produced in the form of oval, white or almost white tablets with a score line for easy division. Each tablet contains a precisely calibrated amount of the active substance, which ensures the predictability of the therapeutic effect and stability of the result throughout the entire course of use. The drug is packaged in blisters that protect the tablets from moisture, light, and mechanical damage, preserving their pharmacological activity until the expiration date. It is important to understand that ARMODACARE 150 is a prescription drug, so its use must occur exclusively as prescribed by a physician after a comprehensive assessment of the patient's health status. Self-medication with psychostimulants can lead to serious sleep disturbances, exhaustion of the nervous system, and other adverse consequences.

What is ARMODACARE 150 prescribed for?

The main indications for the use of ARMODACARE 150 are conditions associated with excessive daytime sleepiness occurring against the background of narcolepsy, obstructive sleep apnea, or shift work sleep disorder. In narcolepsy, the drug helps patients avoid sudden episodes of falling asleep during the day, which significantly reduce the quality of life and can pose a threat to safety while driving or performing professional duties. In the case of obstructive sleep apnea, ARMODACARE 150 is used as an adjunct to primary therapy aimed at restoring normal breathing during sleep. The drug does not eliminate the cause of apnea, but it effectively reduces residual sleepiness that persists even after the correction of respiratory disorders.

ARMODACARE 150 is also prescribed to patients with shift work sleep disorder, when professional activity involves regular night shifts or a rotational work schedule. In such cases, the drug helps maintain an adequate level of alertness and cognitive productivity during hours when the body's biological clock signals a need for rest. This is especially relevant for medical workers, rescuers, long-haul drivers, and operators of complex technological processes. In addition to officially registered indications, in clinical practice, ARMODACARE 150 is sometimes used to improve concentration in attention deficit hyperactivity disorder in adults; however, such use requires special caution and careful medical supervision.

In some cases, a doctor may recommend ARMODACARE 150 for short-term enhancement of mental performance during periods of intense intellectual strain, for example, while preparing for important exams or completing complex projects with tight deadlines. The drug helps reduce the feeling of fatigue, improves the speed of information processing, and maintains motivation to perform monotonous tasks. At the same time, it should be emphasized that ARMODACARE 150 is not a remedy for treating chronic fatigue, depression, or other mental disorders, and its use by healthy individuals to increase productivity should be agreed upon with a medical professional. Uncontrolled use of stimulants can mask the true causes of fatigue, such as anemia, hypothyroidism, or metabolic disorders, which require completely different treatment.

Composition and active components of ARMODACARE 150

The main active substance of ARMODACARE 150 is armodafinil in the amount of 150 mg per tablet. Armodafinil is a chemically pure R-isomer of modafinil, which has higher biological activity and a longer elimination half-life compared to the racemic mixture. The mechanism of action of armodafinil is associated with its effect on the dopaminergic system of the brain: the substance blocks the reuptake of dopamine, increasing its concentration in the synaptic cleft. This leads to the activation of certain areas of the hypothalamus and cerebral cortex responsible for maintaining wakefulness, regulating attention, and emotional tone. Unlike amphetamines, armodafinil does not cause a massive release of dopamine from vesicles, so its stimulating effect is softer and more physiological.

Excipients of ARMODACARE 150 include lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, and magnesium stearate. Lactose monohydrate acts as a filler, providing the necessary mass of the tablet and promoting uniform distribution of the active substance in the dosage form. Microcrystalline cellulose provides the tablet with strength and stability, preventing its breakdown during transportation and storage. Croscarmellose sodium acts as a disintegrant, a substance that promotes rapid breakdown of the tablet in the gastrointestinal tract and release of the active component. Povidone ensures binding of the ingredients into a single structure, and magnesium stearate functions as a lubricant, facilitating the tableting process on manufacturing equipment.

Pharmacokinetic features of armodafinil ensure rapid absorption of the drug after oral administration, reaching peak plasma concentration in approximately 2–3 hours. The bioavailability of armodafinil is high and practically independent of food intake, although fatty food may slightly slow down the rate of absorption. The metabolism of armodafinil occurs mainly in the liver with the participation of cytochrome P450 enzymes, particularly the CYP3A4 isoenzyme, forming inactive metabolites that are excreted by the kidneys. The elimination half-life is about 15 hours, allowing a therapeutic concentration of the drug to be maintained throughout the day after a single morning dose. This pharmacokinetic profile makes ARMODACARE 150 convenient for patients requiring a prolonged period of alertness without the need for repeated dosing.

Dosage of ARMODACARE 150

The standard recommended dose of ARMODACARE 150 for adult patients is 150 mg once daily, preferably in the morning hours. For patients with shift work sleep disorder, the drug is taken approximately one hour before the start of the work shift, regardless of the time of day. This dosage regimen provides an optimal therapeutic effect throughout the period of active work and minimizes the risk of night sleep disturbance. In case of insufficient clinical response, the doctor may consider increasing the dose to 250 mg per day; however, such a decision is made individually, taking into account the tolerability of the drug and the severity of symptoms. Exceeding the recommended dose without medical supervision is strictly prohibited due to an increased risk of side effects.

The duration of the treatment course with ARMODACARE 150 is determined by the doctor depending on the nature of the underlying disease and the patient's individual response to therapy. In narcolepsy and obstructive sleep apnea, the drug may be prescribed for a long period with regular assessment of efficacy and safety of use. For patients with shift work sleep disorder, ARMODACARE 150 is usually used only on work shift days, and during rest periods, the drug is discontinued to prevent the development of tolerance and sleep disturbances. It is important to periodically review the need to continue therapy, as long-term use of psychostimulants can lead to a decrease in their effectiveness or the formation of psychological dependence.

For elderly patients, dose adjustment of ARMODACARE 150 is usually not required; however, due to a possible decrease in liver and kidney function, it is recommended to start therapy with the minimum effective dose and carefully monitor the patient's condition. In patients with severe hepatic impairment, the dose of the drug should be reduced by half, as armodafinil metabolism occurs precisely in this organ. In severe renal impairment, cautious use with monitoring of the clinical condition is also recommended. Any dosage change should be carried out exclusively in agreement with the doctor, who possesses full information about the patient's health status and concomitant therapy.

How to properly take ARMODACARE 150?

ARMODACARE 150 is taken orally, swallowing the tablet with a sufficient amount of water, regardless of food intake. However, it should be considered that consuming fatty food immediately before taking the drug may slow down its absorption and delay the onset of the therapeutic effect. To achieve maximum efficacy, it is recommended to take ARMODACARE 150 at the same time every day, which helps form a stable concentration of the active substance in the body. The tablet should be swallowed whole, without chewing or crushing, as breaking the integrity of the dosage form can affect the release rate of the active component. If it is difficult for the patient to swallow the tablet whole, dividing it along the score lines into parts is allowed, but crushing it into a powder is not recommended.

In case of a missed dose of ARMODACARE 150, the patient should take the drug as soon as possible if there is enough time before the next intake. However, if the time for the next dose is approaching or less than 8–10 hours remain until scheduled sleep, the missed dose should be skipped and the regular schedule resumed. Doubling the dose to compensate for a missed one is strictly forbidden, as this can lead to an overdose and the development of serious adverse reactions. Patients taking ARMODACARE 150 should avoid alcohol consumption throughout the treatment period, as ethanol can increase toxic stress on the liver and unpredictably alter the action of the drug. It is also important to maintain an adequate sleep and rest schedule, as the drug does not replace the body's physiological need for recovery.

During the use of ARMODACARE 150, it is recommended to periodically monitor blood pressure and heart rate, especially in the first weeks of therapy. The drug may cause a slight increase in blood pressure and an accelerated pulse, which usually does not require discontinuation of treatment, but requires dynamic observation. Women of childbearing age taking hormonal contraceptives should be aware that armodafinil can reduce their effectiveness due to the induction of liver enzymes. In this regard, it is recommended to use additional or alternative methods of contraception during treatment and for one month after its completion. Before starting therapy, be sure to inform your doctor about all medicines you are taking, including over-the-counter drugs, dietary supplements, and herbal remedies.

Side effects of ARMODACARE 150

The most common side effects of ARMODACARE 150 are headache, nausea, decreased appetite, dry mouth, and insomnia. Headache usually occurs at the beginning of therapy and tends to decrease or completely disappear during the first days of using the drug. Nausea and decreased appetite are associated with the effect of armodafinil on the hunger regulation centers in the hypothalamus and usually do not require special treatment. Insomnia is most often observed when taking the drug in the second half of the day or when exceeding the recommended dose, so it is important to adhere to the morning dosage schedule. Dry mouth can be reduced by regular water intake or using special oral moisturizers.

Less common adverse reactions of ARMODACARE 150 include anxiety, irritability, dizziness, tachycardia, and increased blood pressure. Some patients may experience gastrointestinal disorders, such as diarrhea, constipation, or abdominal pain. Rarely, skin reactions occur in the form of a rash, itching, or hives, which may indicate hypersensitivity to the components of the drug. Serious allergic reactions, such as angioedema or anaphylaxis, occur extremely rarely, but require immediate discontinuation of the drug and emergency medical attention. Patients should know that the appearance of any unusual symptoms during treatment is a reason to consult a doctor, even if these symptoms are not mentioned in the leaflet.

Rare but potentially serious side effects of ARMODACARE 150 are psychiatric disorders, including hallucinations, mania, depression, and suicidal thoughts. Particular attention should be paid to patients with a history of mental illness, as their risk of symptom exacerbation is higher. Cases of severe skin reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, have also been described, requiring immediate drug withdrawal and hospitalization. If a rash appears accompanied by fever, joint pain, or general malaise, you should immediately stop taking ARMODACARE 150 and consult a doctor. The body's individual reaction to the drug can vary significantly, so every patient's well-being requires a separate evaluation.

Contraindications of ARMODACARE 150

ARMODACARE 150 has a number of absolute contraindications, in the presence of which the use of the drug is strictly forbidden. These include hypersensitivity to armodafinil, modafinil, or any excipient of the dosage form. The drug is not prescribed to patients with severe cardiovascular diseases, including uncontrolled arterial hypertension, recent myocardial infarction, unstable angina, or serious heart rhythm disturbances. Patients with left ventricular hypertrophy or mitral valve prolapse accompanied by clinical manifestations should also avoid using ARMODACARE 150 due to the risk of hemodynamic deterioration. The presence of psychotic disorders, severe depression, or bipolar affective disorder is a contraindication to prescribing the drug.

Relative contraindications to the use of ARMODACARE 150 are moderate arterial hypertension, impaired liver and kidney function, as well as a predisposition to anxiety disorders. In such cases, the drug can be prescribed only after a careful assessment of the benefit-risk ratio, with mandatory monitoring of the patient's condition throughout the treatment period. ARMODACARE 150 is not recommended for pregnant women, as safety data on the use of armodafinil during pregnancy are limited, and animal studies have shown potential adverse effects on fetal development. Women of childbearing potential should rule out pregnancy before starting therapy and use reliable methods of contraception during treatment. The breastfeeding period is also a contraindication, as it is unknown whether armodafinil passes into breast milk.

ARMODACARE 150 is not prescribed to children and adolescents under 18 years of age due to the lack of sufficient data on efficacy and safety in this age group. For elderly patients, the drug may be prescribed with caution, as they are more likely to have concomitant diseases and reduced functional reserves of the body. In individuals with a history of drug or alcohol dependence, ARMODACARE 150 should be used under strict medical supervision due to the potential risk of abuse. Before starting therapy, be sure to inform your doctor about all existing diseases, allergic reactions, and medications you are taking to avoid dangerous interactions and complications.

Interaction of ARMODACARE 150 with other drugs and alcohol

ARMODACARE 150 can interact with a number of medicinal products, which requires special attention during combination therapy. Armodafinil is an inducer of cytochrome P450 enzymes, particularly CYP3A4, so it can reduce the effectiveness of drugs metabolized by this enzyme. Such agents include hormonal contraceptives, cyclosporine, certain antiviral drugs, antidepressants, and anticonvulsants. Concomitant use of ARMODACARE 150 with warfarin or other anticoagulants requires regular monitoring of blood clotting parameters, as a reduction in their therapeutic effect is possible. Patients taking any medication on a permanent basis must inform their doctor before starting ARMODACARE 150 therapy.

Alcohol consumption during treatment with ARMODACARE 150 is strictly not recommended, as ethanol can worsen the side effects of the drug and create an additional burden on the liver. Alcohol can mask or, conversely, enhance the stimulating effect of armodafinil on the central nervous system, which can lead to unpredictable reactions, including pronounced psychomotor agitation or, conversely, depression of consciousness. The drug can affect reaction speed and the ability to drive vehicles, especially at the beginning of therapy or when changing the dosage. Patients should refrain from driving a car and working with hazardous machinery until they are sure that the drug does not cause them dizziness, drowsiness, or other impairments capable of affecting safety.

Where to buy ARMODACARE 150 in Ukraine

ARMODACARE 150 is available for purchase in pharmacy establishments in Ukraine with a doctor's prescription, as the drug belongs to the category of prescription medicines. Before purchasing, it is recommended to clarify the availability of the drug at a specific pharmacy, as the demand for specialized agents of this type may exceed supply in certain regions. Many patients prefer online ordering through official pharmacy network platforms, which allows checking availability in advance, comparing prices, and choosing a convenient method of receipt. The cost of ARMODACARE 150 may vary depending on the pharmacy chain, region, and current promotional offers, so it is advisable to monitor prices before purchasing.

ARMODACARE 150 should be stored in a dry place protected from light at a temperature not exceeding 25 degrees Celsius, out of the reach of children. The shelf life of the drug is usually 24 months from the date of manufacture, after which the use of the product is prohibited. Before starting ARMODACARE 150, be sure to consult a doctor to determine the appropriateness of therapy, correct dosage, and rule out possible contraindications. Remember that self-medication with psychostimulants can be dangerous to health, and the body's individual reaction to the drug requires professional evaluation and dynamic observation.